However, further analysis suggested that the MCL patients with triple-positive (or triple-high) expression (H-scores p53 > 40, Sox11 > 100, and Pax5 > 100) of target proteins had significantly inferior PFS and OS (Fig. 4e). This evidence concerns the gene SOX11 and mantle cell lymphoma.